Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion type Assertion NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_head.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion wasGeneratedBy ECO_0000203 NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion wasDerivedFrom befree-20140225 NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion SIO_000772 19340428 NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion evidence source_evidence_literature NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.